Related Experiment Video
Updated: Feb 20, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
[Proton pump inhibitors overprescription]
Marie Esteves1, Victoria Rollason2, Olivier Grosgurin1
1Service de médecine interne générale, Département de médecine interne, réhabilitation et gériatrie, HUG, 1211 Genève 14.
Proton pump inhibitor (PPI) overuse is common, leading to clinical and economic problems. Limiting new PPI prescriptions and regularly reviewing existing ones is crucial to address this issue.
Area of Science:
- Pharmacology and Therapeutics
- Clinical Medicine
- Health Economics
Background:
- Proton pump inhibitors (PPIs) are frequently overutilized despite established guidelines.
- This overuse leads to significant clinical and economic burdens.
- Common drivers include inappropriate stress ulcer prophylaxis and automatic renewal of prescriptions.
Purpose of the Study:
- To highlight the issue of proton pump inhibitor (PPI) overutilization.
- To identify key factors contributing to PPI overuse.
- To emphasize the need for improved prescribing practices and regular treatment reassessment.
Main Methods:
- Review of clinical practice and prescribing patterns for PPIs.
- Analysis of reasons for PPI initiation and continuation.
- Assessment of challenges in discontinuing PPI therapy.
Main Results:
- Overutilization of PPIs is evident, contravening recommendations.
- Abusive stress ulcer prophylaxis and automatic represcription are primary causes.
- Difficulty in interrupting PPIs can be exacerbated by withdrawal symptoms.
Conclusions:
- It is imperative to restrict the initiation of PPI treatment to appropriate indications.
- Regular reassessment of the ongoing need for PPI therapy is mandatory.
- Addressing PPI overuse requires a multi-faceted approach including prescriber education and patient management strategies.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

